European Healthtech startup funding raised during Q4 2023.
In Q4 2023, 120 European Healthtech companies raised a combined €857M across 121 funding rounds, down 56.7% versus Q4 2022. France led by capital raised, and Fongit Innovation Fund (FIF) was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Aqemia | Other | Dec 2023 | €129M |
| Agomab Therapeutics | Series C | Oct 2023 | €95M |
| EyeBiotech | Series A | Nov 2023 | €61M |
| MinervaX | Other | Oct 2023 |
| €54M |
| In Ovo | Debt | Nov 2023 | €40M |
| Automata Technologies | Other | Oct 2023 | €38M |
| Eligo Bioscience | Series B | Dec 2023 | €28M |
| Memo Therapeutics | Series C | Nov 2023 | €26M |
| Bioserenity | Other | Nov 2023 | €24M |
| ViaNautis | Series A | Nov 2023 | €23M |
| Cradle | Series A | Nov 2023 | €22M |
| LUMA Vision | Series A | Dec 2023 | €20M |
| Inbrain Neuroelectronics | Debt | Dec 2023 | €20M |
| Lottie | Series A | Oct 2023 | €20M |
| Laverock Therapeutics | Seed | Oct 2023 | €16M |
